Cite
HARVARD Citation
Tabouret, E. et al. (n.d.). MMP2 and MMP9 as candidate biomarkers to monitor bevacizumab therapy in high-grade glioma. Neuro-oncology. 17 (8), pp. 1174-1176. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tabouret, E. et al. (n.d.). MMP2 and MMP9 as candidate biomarkers to monitor bevacizumab therapy in high-grade glioma. Neuro-oncology. 17 (8), pp. 1174-1176. [Online].